Previous studies have shown that prostaglandin E2 (PGE2) plays an important role in AKI and CKD, which signals primarily through four G protein-coupled receptors, including E-type prostaglandin receptor (EP) one to EP4 (Crittenden et al., 2021; Minhas et al., 2021). This evidence concerns the gene PTGER4 and chronic kidney disease.